Revvity Quick Ratio 2010-2025 | RVTY
Historical quick ratio values for Revvity (RVTY) over the last 10 years.
| Revvity Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $1.94B | $0.65B | 2.99 |
| 2024-12-31 | $1.98B | $0.65B | 3.04 |
| 2024-09-30 | $2.04B | $0.69B | 2.97 |
| 2024-06-30 | $2.76B | $1.39B | 1.98 |
| 2024-03-31 | $2.65B | $1.37B | 1.93 |
| 2023-12-31 | $2.57B | $1.45B | 1.77 |
| 2023-09-30 | $2.48B | $1.45B | 1.71 |
| 2023-06-30 | $3.09B | $1.37B | 2.26 |
| 2023-03-31 | $3.37B | $1.56B | 2.15 |
| 2022-12-31 | $2.88B | $1.54B | 1.87 |
| 2022-09-30 | $2.74B | $1.49B | 1.84 |
| 2022-06-30 | $1.48B | $1.04B | 1.42 |
| 2022-03-31 | $1.81B | $1.26B | 1.43 |
| 2021-12-31 | $2.02B | $1.21B | 1.66 |
| 2021-09-30 | $1.61B | $1.15B | 1.40 |
| 2021-06-30 | $1.75B | $1.12B | 1.56 |
| 2021-03-31 | $2.15B | $1.52B | 1.41 |
| 2020-12-31 | $1.72B | $1.65B | 1.04 |
| 2020-09-30 | $1.19B | $1.25B | 0.96 |
| 2020-06-30 | $1.05B | $1.16B | 0.91 |
| 2020-03-31 | $0.95B | $0.73B | 1.30 |
| 2019-12-31 | $1.02B | $0.76B | 1.33 |
| 2019-09-30 | $1.16B | $1.19B | 0.97 |
| 2019-06-30 | $0.92B | $0.71B | 1.31 |
| 2019-03-31 | $0.87B | $0.74B | 1.17 |
| 2018-12-31 | $0.90B | $0.77B | 1.16 |
| 2018-09-30 | $0.81B | $0.69B | 1.18 |
| 2018-06-30 | $0.84B | $0.71B | 1.17 |
| 2018-03-31 | $0.86B | $0.93B | 0.93 |
| 2017-12-31 | $0.85B | $0.95B | 0.89 |
| 2017-09-30 | $1.25B | $0.60B | 2.09 |
| 2017-06-30 | $1.16B | $0.59B | 1.97 |
| 2017-03-31 | $0.85B | $0.60B | 1.42 |
| 2016-12-31 | $0.94B | $0.60B | 1.56 |
| 2016-09-30 | $0.85B | $0.55B | 1.55 |
| 2016-06-30 | $0.78B | $0.56B | 1.39 |
| 2016-03-31 | $0.74B | $0.56B | 1.33 |
| 2015-12-31 | $0.77B | $0.56B | 1.38 |
| 2015-09-30 | $0.76B | $0.55B | 1.37 |
| 2015-06-30 | $0.77B | $0.57B | 1.33 |
| 2015-03-31 | $0.73B | $0.55B | 1.33 |
| 2014-12-31 | $0.78B | $0.60B | 1.31 |
| 2014-09-30 | $0.79B | $0.57B | 1.40 |
| 2014-06-30 | $0.80B | $0.58B | 1.39 |
| 2014-03-31 | $0.82B | $0.61B | 1.35 |
| 2013-12-31 | $0.78B | $0.60B | 1.30 |
| 2013-09-30 | $0.67B | $0.59B | 1.14 |
| 2013-06-30 | $0.65B | $0.56B | 1.15 |
| 2013-03-31 | $0.64B | $0.57B | 1.11 |
| 2012-12-31 | $0.72B | $0.58B | 1.25 |
| 2012-09-30 | $0.68B | $0.58B | 1.17 |
| 2012-06-30 | $0.65B | $0.59B | 1.11 |
| 2012-03-31 | $0.66B | $0.60B | 1.09 |
| 2011-12-31 | $0.64B | $0.60B | 1.07 |
| 2011-09-30 | $0.70B | $0.88B | 0.80 |
| 2011-06-30 | $0.85B | $0.56B | 1.53 |
| 2011-03-31 | $0.86B | $0.51B | 1.69 |
| 2010-12-31 | $0.88B | $0.52B | 1.70 |
| 2010-09-30 | $0.77B | $0.51B | 1.49 |
| 2010-06-30 | $0.69B | $0.51B | 1.35 |
| 2010-03-31 | $0.66B | $0.50B | 1.33 |
| 2009-12-31 | $0.71B | $0.50B | 1.42 |
| 2009-09-30 | $0.63B | $0.51B | 1.22 |
| 2009-06-30 | $0.60B | $0.50B | 1.22 |
| 2009-03-31 | $0.58B | $0.47B | 1.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.529B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $132.070B | 24.77 |
| Elevance Health (ELV) | United States | $84.109B | 10.85 |
| CVS Health (CVS) | United States | $76.951B | 9.56 |
| Cencora (COR) | United States | $56.664B | 19.71 |
| DiDi Global (DIDIY) | China | $22.591B | 34.29 |
| Natera (NTRA) | United States | $20.935B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.529B | 0.00 |
| Solventum (SOLV) | United States | $12.251B | 12.97 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| ICON (ICLR) | Ireland | $10.336B | 9.61 |
| Viatris (VTRS) | United States | $9.730B | 3.34 |
| Doximity (DOCS) | United States | $9.525B | 44.37 |
| Avantor (AVTR) | United States | $8.647B | 12.56 |
| HealthEquity (HQY) | United States | $8.564B | 42.13 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.176B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.716B | 13.16 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.048B | 37.47 |
| Bausch + Lomb (BLCO) | Canada | $3.990B | 23.52 |
| Sotera Health (SHC) | United States | $3.452B | 19.61 |
| Surgery Partners (SGRY) | United States | $2.922B | 38.00 |
| Alignment Healthcare (ALHC) | United States | $2.865B | 0.00 |
| Concentras Parent (CON) | United States | $2.710B | 15.66 |
| Organon (OGN) | United States | $2.259B | 2.40 |
| Ardent Health Partners (ARDT) | United States | $2.091B | 8.91 |
| GeneDx Holdings (WGS) | United States | $2.043B | 78.68 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.759B | 38.72 |
| PACS (PACS) | United States | $1.497B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.336B | 26.71 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.944B | 14.74 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| Nutex Health (NUTX) | United States | $0.890B | 13.45 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 7.44 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.626B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Enhabit (EHAB) | United States | $0.518B | 42.58 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 11.08 |
| SBC Medicals (SBC) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.462B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.408B | 0.00 |
| Oncology Institute (TOI) | United States | $0.269B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.215B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.137B | 22.33 |
| OncoCyte (OCX) | United States | $0.096B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.066B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |